Efficacy of Inotuzumab Ozogamicin plus Ponatinib Followed by Allogeneic Stem Cell Transplantation in a Patient with Relapsed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph + ALL) is an aggressive disease with poor outcomes. Despite the incorporation of tyrosine kinase inhibitors (TKIs) in the therapeutic strategies, patients who relapse after chemotherapy plus TKI have poor overall survival (OS) and les...

Descripción completa

Detalles Bibliográficos
Autores principales: Micheva, Ilina, Gerov, Vladimir, Dimitrova, Stela, Efraim, Merlin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175171/
https://www.ncbi.nlm.nih.gov/pubmed/34136291
http://dx.doi.org/10.1155/2021/1717506

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175171/
https://www.ncbi.nlm.nih.gov/pubmed/34136291
http://dx.doi.org/10.1155/2021/1717506

Ejemplares similares